HeartFlow Analysis vs KardiaAI
AI Verdict
Choose HeartFlow Analysis if…
Choose HeartFlow Analysis if you need a non-invasive, comprehensive diagnostic assessment of coronary artery disease (CAD) from standard CT scans. This tool is ideal for evaluating the anatomical and functional significance of coronary stenoses, including plaque analysis and FFRct, to guide treatment decisions and potentially avoid invasive procedures.
View HeartFlow Analysis →Choose KardiaAI if…
Choose KardiaAI if you require an AI-powered solution for analyzing ambulatory ECG rhythms to detect various cardiac conditions like AFib, bradycardia, or tachycardia. This tool is best suited for integrating into mobile or web platforms for continuous or intermittent heart rhythm monitoring, aiding in the management and early detection of arrhythmias in an outpatient setting.
View KardiaAI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | HeartFlow Analysis | KardiaAI |
|---|---|---|
| Pricing | Contact vendor for pricing | Subscription-based for advanced features and services. |
| Deployment | Cloud-based (AWS) | Mobile app, cloud-based. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
KardiaAIKardiaAI, as an API library integrated into mobile apps and web platforms, offers broader accessibility and ease of use for both clinicians and potentially patients for monitoring. HeartFlow Analysis, while cloud-based, is a specialized diagnostic tool requiring expert interpretation of complex 3D models from CT scans, limiting its general usability to specialists.
Clinical Value
HeartFlow AnalysisHeartFlow Analysis provides a non-invasive alternative to invasive Fractional Flow Reserve (FFR) for diagnosing and managing coronary artery disease, directly impacting high-stakes treatment decisions with its FFRct and plaque analysis. While KardiaAI offers valuable early detection of arrhythmias, HeartFlow's solution addresses a more complex diagnostic challenge with significant implications for patient management and intervention.
Pricing & Value
HeartFlow AnalysisHeartFlow Analysis benefits from established Category I CPT codes for FFRct and Plaque Analysis, along with CMS payment rates and coverage by Medicare and most U.S. commercial payers, providing clear reimbursement pathways for healthcare providers. This fee-for-service model with established financial integration offers a strong value proposition for enterprise adoption, whereas KardiaAI's subscription model is more geared towards individual or smaller-scale integrations.
Enterprise Readiness
HeartFlow AnalysisHeartFlow Analysis demonstrates strong enterprise readiness through its cloud-based (AWS) deployment, HIPAA compliance, BAA, FDA clearance, and crucially, established reimbursement pathways with major payers. These factors facilitate seamless integration into existing healthcare system workflows and financial structures. While KardiaAI's API library supports integration, HeartFlow's comprehensive solution and financial framework make it more directly ready for enterprise-level adoption.
Innovation
HeartFlow AnalysisHeartFlow Analysis showcases greater innovation by utilizing AI for complex 3D modeling of coronary arteries and computational fluid dynamics (CFD) to non-invasively derive FFRct, a measurement previously requiring invasive procedures. This represents a significant advancement in diagnostic capabilities for coronary artery disease. KardiaAI's AI-powered ECG analysis is valuable but builds on more established diagnostic principles.
Support & Docs
TieThe provided structured facts do not contain sufficient information to assess the quality or availability of support and documentation for either HeartFlow Analysis or KardiaAI. Therefore, a definitive winner cannot be determined for this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | HeartFlow Analysis | KardiaAI |
|---|---|---|
| Product Name | HeartFlow Analysis | KardiaAI |
| Company | HeartFlow | AliveCor |
| Primary AI Focus | Non-invasive solution for diagnosing and managing coronary artery disease (CAD) by creating personalized 3D models of patients' coronary arteries from standard CT scans. | Analyzing ambulatory ECG rhythms, detecting various cardiac conditions like AFib, bradycardia, and tachycardia. |
| Insurance/Medicare Coverage | Covered by Medicare and most U.S. commercial payers; Category I CPT code for FFRct Analysis (75580) and AI-Enabled Quantitative Plaque Analysis (75577 for 2026); CMS payment rates for FFRct Analysis and Plaque Analysis are established. | Not specified |
| Key Analyses/Detections | AI-powered 3D modeling of coronary arteries, Fractional Flow Reserve derived from CT (FFRct) analysis, Plaque Analysis (quantification and characterization), Roadmapu2122 Analysis for CCTA reading, Computational Fluid Dynamics (CFD) for blood flow simulation. | AI-powered ECG analysis library, Detection of atrial fibrillation, bradycardia, tachycardia, normal sinus rhythm, Sinus Rhythm with Premature Ventricular Contractions (PVCs), Sinus Rhythm with Wide QRS, Sinus Rhythm with Supraventricular Ectopy (SVE), ECG noise filtering and noisy ECG detection. |
| Specialties | Cardiology, Radiology | Cardiology, Emergency Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring HeartFlow Analysis and KardiaAI.
Frequently Asked Questions
More Comparisons
More matchups featuring HeartFlow Analysis or KardiaAI
Backers
Who funded each tool's parent company.